Shree Ram Proteins Board Meeting: Approves Q1 FY27 & FY26 Results, Faces Going Concern Uncertainty
Shree Ram Proteins board met on August 17, 2026, approving Q1 FY27 unaudited and FY26 audited results. The company faces severe financial distress, with auditors issuing an adverse opinion due to a material uncertainty regarding its going concern status. Defaults on loans and statutory dues are reported, alongside a significant working capital shortage.
The adverse audit opinion and the company's precarious financial situation, including defaults and potential cessation of operations, have a high impact on stakeholders, including investors, creditors, and employees.
The company's financial results are overshadowed by an adverse audit opinion, highlighting material uncertainties about its ability to continue as a going concern. Defaults on loans and statutory dues, coupled with a working capital shortage and auction of assets, indicate a severely negative financial outlook.
Shree Ram Proteins Limited held a Board Meeting on August 17, 2026, to consider and approve financial results. The Board approved the unaudited financial results for the quarter ended June 30, 2026, and the audited financial results for the quarter and year ended March 31, 2026.
However, the company's financial health remains a significant concern. The auditors have issued an adverse opinion, highlighting a material uncertainty related to the company's going concern status. Shree Ram Proteins has defaulted on loan repayments and statutory dues. Furthermore, the company is facing a working capital shortage and has had its plant and machinery auctioned by Union Bank of India for ₹382.00 Lakhs due to loan defaults. The auditors were unable to obtain sufficient audit evidence for various aspects, including inventory, fixed assets, and balance confirmations, due to management's failure to conduct necessary inspections and reconciliations. The company is currently exploring avenues to mitigate its circumstances.
What to do with a filing like this
Shree Ram Proteins Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Shree Ram Proteins Limited. Read the original for the full detail.